share_log

Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023

Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023

鸚鵡螺生物技術將於2023年10月31日公佈第三季度財務業績
Nautilus Biotechnology ·  2023/10/11 12:00

SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the third quarter before market open on Tuesday, October 31, 2023.

西雅圖,2023年10月11日(環球網)--領先的單分子蛋白質分析平臺公司鸚鵡螺生物技術公司(納斯達克:NAUT;或“Nautilus”)今天宣佈,將於2023年10月31日(星期二)開市前公佈第三季度財務業績。

The company's management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the "Investors" section of the company website at: www.nautilus.bio.

該公司管理層將於凌晨5:30開始網路直播相應的電話會議。太平洋時間/上午8:30東部時間討論其業績、業務發展和前景。網路直播的現場音頻將在該公司網站的“投資者”欄目中播放,網址為:Www.nautilus.bio

About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus' mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

鸚鵡螺生物技術公司簡介
Nautilus公司總部設在華盛頓州西雅圖,研發總部設在加利福尼亞州聖卡洛斯,是一家處於發展階段的生命科學公司,致力於創建一種量化和解鎖蛋白質組複雜性的平臺技術。Nautilus的使命是通過使獲得蛋白質組的途徑民主化並使人類健康和醫學取得根本性進展來改變蛋白質組學領域。要了解更多有關鸚鵡螺的資訊,請訪問Www.nautilus.bio

Media Contact
press@nautilus.bio

媒體聯繫人
郵箱:Press@nautilus.bio

Investor Contact
investorrelations@nautilus.bio

投資者聯繫方式
郵箱:Investorrelationsnautilus.bio

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論